GeneDx Holdings Corp.
WGS
$85.74
-$5.87-6.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 85.76M | 94.20M | 77.42M | 69.44M | 61.10M |
| Total Other Revenue | 1.36M | 1.44M | -544.00K | 1.08M | 1.32M |
| Total Revenue | 87.12M | 95.64M | 76.87M | 70.51M | 62.42M |
| Cost of Revenue | 28.64M | 29.44M | 29.04M | 27.56M | 24.96M |
| Gross Profit | 58.48M | 66.21M | 47.84M | 42.95M | 37.46M |
| SG&A Expenses | 50.45M | 43.48M | 43.17M | 41.76M | 39.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 785.00K | 774.00K | 874.00K | -- |
| Total Operating Expenses | 91.67M | 85.14M | 84.65M | 81.09M | 76.03M |
| Operating Income | -4.55M | 10.50M | -7.77M | -10.58M | -13.61M |
| Income Before Tax | -6.08M | 5.41M | -8.36M | -29.36M | -20.32M |
| Income Tax Expenses | 447.00K | -24.00K | -47.00K | -190.00K | -82.00K |
| Earnings from Continuing Operations | -6.53M | 5.44M | -8.31M | -29.17M | -20.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.53M | 5.44M | -8.31M | -29.17M | -20.24M |
| EBIT | -4.55M | 10.50M | -7.77M | -10.58M | -13.61M |
| EBITDA | 1.13M | 15.16M | -1.85M | -5.36M | -8.36M |
| EPS Basic | -0.23 | 0.20 | -0.31 | -1.10 | -0.78 |
| Normalized Basic EPS | -0.14 | 0.45 | -0.19 | -0.69 | -0.49 |
| EPS Diluted | -0.23 | 0.20 | -0.31 | -1.10 | -0.78 |
| Normalized Diluted EPS | -0.14 | 0.45 | -0.19 | -0.69 | -0.49 |
| Average Basic Shares Outstanding | 28.15M | 27.78M | 27.10M | 26.62M | 26.06M |
| Average Diluted Shares Outstanding | 28.15M | 27.78M | 27.10M | 26.62M | 26.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |